Doylestown, Pennsylvania, United StatesFounded 202128+ employeesPrivate
$12.3M raisedSeries A· last: series a (Sep 2024)· 2 rounds
Backed by(3 investors)
Korio is the Randomization & Trial Supply Management (RTSM) platform designed for flexibility, quality and speed. Not just built to tackle clinical trial challenges as they come, but built to prevent them in the first place. No matter what trials you may face, Korio is prepared to handle them.
